Medication Optimization Using Pharmacogenetic Testing and the G-DIG to Reduce Polypharmacy in a Mental Health Population

NCT03468309 · clinicaltrials.gov ↗
COMPLETED
Status
53
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Seattle Institute for Biomedical and Clinical Research

Collaborators